Skip to main content
Caplight Logo









Xsphera Biosciences

Xsphera Biosciences

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.xspherabio.com/

Last Round

Seed

Jun 15, 2022

Total Funding Raised

$481,800

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Xsphera Biosciences is a biotechnology company that provides a fresh human tumor tissue-based platform for oncology therapeutic testing and drug development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

ex vivo tumor modelimmuno-oncologydrug discoveryprecision medicinecontract research organizationCROtumor microenvironmentpatient-derived tissueorganoidpre-clinical researchtranslational researchdrug efficacy testinghigh-content screeninglab-on-a-chipbiotech services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Xsphera Biosciences Comparables

Compare Xsphera Biosciences with similar companies based on industry and business-model similarity.

Xsphera Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VitroScan
89%
Kiyatec
88%
Xilis
87%

Xsphera Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 15, 2022
GrantDec 12, 2019

Key People

Founding team and executive leadership

Stephen Remondi

CEO Founder

Founding Team

Kevin Horrigan

Chief Technology Officer

Executive Team

Xsphera Biosciences Investors

Notable investors and investment history

Xsphera Biosciences investors
InvestorRounds
U.S. Department of Health and Human ServicesGrant
Aquila Capital PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 46% MoM, reaching 1.7K.

  • May 1, 2025

    Monthly visitors grew 764% MoM, reaching 1.4K.

Xsphera Biosciences Filings

Explore SEC and related filing metadata, where available.

Xsphera Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Xsphera Biosciences's valuation, stock price, and market status.

Is Xsphera Biosciences a public or private company?

Xsphera Biosciences is a private company.

What is the current stock price of Xsphera Biosciences?

Xsphera Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is Xsphera Biosciences worth (valuation)?

Valuation information for Xsphera Biosciences is not publicly available.

Can I buy Xsphera Biosciences stock?

Xsphera Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Xsphera Biosciences's last funding round?

Xsphera Biosciences's most recent funding round was Seed on June 15, 2022.

Who are the main investors in Xsphera Biosciences?

Key investors in Xsphera Biosciences include U.S. Department of Health and Human Services, Aquila Capital Partners.

Will Xsphera Biosciences IPO soon?

No public IPO plans have been announced for Xsphera Biosciences.

How can I track Xsphera Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Xsphera Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range13
Year Founded2018
Last FundingJun 15, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?